J
Juan Wang
Researcher at Anhui University of Chinese Medicine
Publications - 8
Citations - 67
Juan Wang is an academic researcher from Anhui University of Chinese Medicine. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 10 citations.
Papers
More filters
Journal ArticleDOI
Ginsenoside Rg1 Prevents PTSD-Like Behaviors in Mice Through Promoting Synaptic Proteins, Reducing Kir4.1 and TNF-α in the Hippocampus
TL;DR: Novel protective effects of ginsenoside Rg1 are revealed against PTSD-like behaviors in mice, likely via promoting synaptic proteins, reducing Kir4.1 and TNF-α in the hippocampus.
Journal ArticleDOI
Neuroinflammation Involved in Diabetes-Related Pain and Itch
TL;DR: An overview of the current understanding of neuroinflammation in contributing to the sensitization of the peripheral nervous system and central nervous system is provided and the inflammation mechanisms that contribute to the pathogenesis of diabetic itch are summarized.
Journal ArticleDOI
cAMP-PKA cascade: An outdated topic for depression?
TL;DR: In this paper , the authors proposed to reconsider the function of the cyclic AMP/protein kinase A (PKA) cascade, especially in the rapid antidepressant effect, and showed that local activation or indirect activation of PKA through adjusting anchor proteins would provide new idea for acute treatment of depression.
Journal ArticleDOI
Anshen Dingzhi prescription in the treatment of PTSD in mice: Investigation of the underlying mechanism from the perspective of hippocampal synaptic function.
Shaojie Yang,Yan Qu,Juan Wang,Feng Gao,M. Ji,Pan Xie,Aisong Zhu,Bei Tan,Xun-Cui Wang,Guoqi Zhu +9 more
TL;DR: In this paper , the authors explored the ameliorative effect of ADP on post-traumatic stress disorder (PTSD)-like behaviors in mice and determine the underlying mechanism.
Journal ArticleDOI
Fear extinction induced by activation of PKA ameliorates anxiety-like behavior in PTSD mice
TL;DR: In this article , the effects of activation of PKA by systemic application of rolipram or meglumine cyclic adenosine 3,5-monophosphate (cAMP)-protein kinase A (PKA), protein kinase B (Akt)/mammalian target of rapamycin (mTOR) and calcium signaling in peripheral serum of PTSD patients using bioinformatics analysis were shown.